422 related articles for article (PubMed ID: 25822790)
21. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information.
Paoletta S; Sabbadin D; von Kügelgen I; Hinz S; Katritch V; Hoffmann K; Abdelrahman A; Straßburger J; Baqi Y; Zhao Q; Stevens RC; Moro S; Müller CE; Jacobson KA
J Comput Aided Mol Des; 2015 Aug; 29(8):737-56. PubMed ID: 26194851
[TBL] [Abstract][Full Text] [Related]
22. Different responses of the blockade of the P2Y1 receptor with BPTU in human and porcine intestinal tissues and in cell cultures.
Traserra S; Barber C; Maclnnes J; Relea L; MacPherson LC; Cunningham MR; Vergara P; Accarino A; Kennedy C; Jimenez M
Neurogastroenterol Motil; 2021 Jul; 33(7):e14101. PubMed ID: 33619847
[TBL] [Abstract][Full Text] [Related]
23. Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents.
Yang W; Wang Y; Lai A; Qiao JX; Wang TC; Hua J; Price LA; Shen H; Chen XQ; Wong P; Crain E; Watson C; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
J Med Chem; 2014 Jul; 57(14):6150-64. PubMed ID: 24931384
[TBL] [Abstract][Full Text] [Related]
24. Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.
Qiao JX; Wang TC; Ruel R; Thibeault C; L'Heureux A; Schumacher WA; Spronk SA; Hiebert S; Bouthillier G; Lloyd J; Pi Z; Schnur DM; Abell LM; Hua J; Price LA; Liu E; Wu Q; Steinbacher TE; Bostwick JS; Chang M; Zheng J; Gao Q; Ma B; McDonnell PA; Huang CS; Rehfuss R; Wexler RR; Lam PY
J Med Chem; 2013 Nov; 56(22):9275-95. PubMed ID: 24164581
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of purinergic inhibitory neuromuscular transmission in the human colon.
Gallego D; Gil V; Aleu J; Martinez-Cutillas M; Clavé P; Jimenez M
Neurogastroenterol Motil; 2011 Aug; 23(8):792-e338. PubMed ID: 21585621
[TBL] [Abstract][Full Text] [Related]
26. P2Y₁ and P2Y₁₂ receptors in hypoxia- and adenosine diphosphate-induced pulmonary vasoconstriction in vivo in the pig.
Kylhammar D; Bune LT; Rådegran G
Eur J Appl Physiol; 2014 Sep; 114(9):1995-2006. PubMed ID: 24929904
[TBL] [Abstract][Full Text] [Related]
27. P2Y(1) receptor mediated neuronal fibre outgrowth in organotypic brain slice co-cultures.
Heine C; Sygnecka K; Scherf N; Grohmann M; Bräsigk A; Franke H
Neuropharmacology; 2015 Jun; 93():252-66. PubMed ID: 25683778
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Potential Orthosteric and Allosteric Antagonists of P2Y1R from Chinese Herbs by Molecular Simulation Methods.
Zhang X; Lu F; Chen YK; Luo GG; Jiang LD; Qiao LS; Zhang YL; Xiang YH
Evid Based Complement Alternat Med; 2016; 2016():4320201. PubMed ID: 27635149
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y
Peng J; Zhao L; Wang L; Chen H; Qiu Y; Wang J; Yang H; Liu J; Liu H
Eur J Med Chem; 2018 Oct; 158():302-310. PubMed ID: 30223118
[TBL] [Abstract][Full Text] [Related]
30. A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis.
Bird JE; Wang X; Smith PL; Barbera F; Huang C; Schumacher WA
J Thromb Thrombolysis; 2012 Aug; 34(2):199-207. PubMed ID: 22588534
[TBL] [Abstract][Full Text] [Related]
31. Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells.
Wei Q; Costanzi S; Liu QZ; Gao ZG; Jacobson KA
Biochem Pharmacol; 2011 Aug; 82(4):418-25. PubMed ID: 21632028
[TBL] [Abstract][Full Text] [Related]
32. P2Y1R is involved in visceral hypersensitivity in rats with experimental irritable bowel syndrome.
Wu J; Cheng Y; Zhang R; Liu D; Luo YM; Chen KL; Ren S; Zhang J
World J Gastroenterol; 2017 Sep; 23(34):6339-6349. PubMed ID: 28974901
[TBL] [Abstract][Full Text] [Related]
33. Diverse signalling of the platelet P2Y
Amison RT; Jamshidi S; Rahman KM; Page CP; Pitchford SC
Eur J Pharmacol; 2018 May; 827():58-70. PubMed ID: 29534999
[TBL] [Abstract][Full Text] [Related]
34. Context-Specific Switch from Anti- to Pro-epileptogenic Function of the P2Y
Alves M; De Diego Garcia L; Conte G; Jimenez-Mateos EM; D'Orsi B; Sanz-Rodriguez A; Prehn JHM; Henshall DC; Engel T
J Neurosci; 2019 Jul; 39(27):5377-5392. PubMed ID: 31048325
[TBL] [Abstract][Full Text] [Related]
35. Tools and drugs for uracil nucleotide-activated P2Y receptors.
Rafehi M; Müller CE
Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
[TBL] [Abstract][Full Text] [Related]
36. Molecular recognition at adenine nucleotide (P2) receptors in platelets.
Jacobson KA; Mamedova L; Joshi BV; Besada P; Costanzi S
Semin Thromb Hemost; 2005 Apr; 31(2):205-16. PubMed ID: 15852224
[TBL] [Abstract][Full Text] [Related]
37. The P2Y1 receptor antagonist MRS2500 prevents carotid artery thrombosis in cynomolgus monkeys.
Wong PC; Watson C; Crain EJ
J Thromb Thrombolysis; 2016 Apr; 41(3):514-21. PubMed ID: 26660522
[TBL] [Abstract][Full Text] [Related]
38. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.
Yanachkov IB; Chang H; Yanachkova MI; Dix EJ; Berny-Lang MA; Gremmel T; Michelson AD; Wright GE; Frelinger AL
Eur J Med Chem; 2016 Jan; 107():204-18. PubMed ID: 26588064
[TBL] [Abstract][Full Text] [Related]
39. New azole antagonists with high affinity for the P2Y(1) receptor.
Ruel R; L'Heureux A; Thibeault C; Daris JP; Martel A; Price LA; Wu Q; Hua J; Wexler RR; Rehfuss R; Lam PY
Bioorg Med Chem Lett; 2013 Jun; 23(12):3519-22. PubMed ID: 23668989
[TBL] [Abstract][Full Text] [Related]
40. Pharmacology and structure of P2Y receptors.
von Kügelgen I; Hoffmann K
Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
